T G Woodworth

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies
    T G Woodworth
    Pfizer Groton R and D, Groton, CT, USA
    J Rheumatol 28:1163-9. 2001

Collaborators

Detail Information

Publications1

  1. ncbi Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies
    T G Woodworth
    Pfizer Groton R and D, Groton, CT, USA
    J Rheumatol 28:1163-9. 2001
    ..Before this tool is widely accepted, its validity, consistency, and feasibility need to be assessed in clinical trials...